Amgen Inc.
High concentration antibody formulations
Last updated:
Abstract:
Discloses herein are high concentration antibody formulations comprising an anti-sclerostin immunoglobulin and an acetate salt and/or an acetate buffer and methods of use.
Status:
Grant
Type:
Utility
Filling date:
26 Jul 2018
Issue date:
22 Jun 2021